AIVF

Tel Aviv, Israel Founded: 2018 • Age: 8 yrs
AI-based platform for analyzing embryos in IVF treatments is provided.

About AIVF

AIVF is a Healthcare company based in Tel Aviv (Israel) founded in 2018 by Daniel Seidman, Daniella Gilboa, and Eyal Schiff. AI-based platform for analyzing embryos in IVF treatments is provided. AIVF has raised $25 million across 1 funding round from investors including Insight Partners and Dan Ariely. AIVF has completed 1 acquisition, including ART Compass. Its chief executive, as recorded, is Daniella Gilboa. Its website aivf.co draws about 17 thousand monthly visits. AIVF offers products and services including EMA Platform, AIVF Day-3, AIVF Day-5, and AIVF Genetics. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations.

Company details

AIVF was established in 2018 in Tel Aviv, Israel, within the healthcare technology sector. An AI-driven diagnosis platform for in vitro fertilization (IVF) is offered. Images and videos of developing embryos are examined through deep learning algorithms. Patient electronic medical records, genomic information, and visual data are integrated to inform critical decisions in treatment processes. Operations focus on supporting fertility clinics with data-driven insights.

  • Headquarters Tel Aviv, Israel
  • Founders Daniel Seidman, Daniella Gilboa, Eyal Schiff
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website aivf.co
  • Social LinkedIn X Facebook Instagram
Key Metrics
  • Total Equity Funding
    $25M (USD)

    in 1 rounds

  • Latest Funding Round
    $25M (USD), Series A

    Jun 2022

  • Investors
  • Investments & Acquisitions

Products & Services of AIVF

AIVF offers a comprehensive portfolio of products and services, including EMA Platform, AIVF Day-3, AIVF Day-5, and AIVF Genetics.

EMA Platform
AI-powered IVF Tool

Platform for embryo evaluation to improve IVF success rates.

AIVF Day-3
IVF Analysis Software

Tool for assessing day-3 embryos in fertility treatments.

AIVF Day-5
IVF Analysis Software

Software for evaluating day-5 embryos to enhance outcomes.

AIVF Genetics
Genetic Analysis Tool

Service for genetic screening in IVF processes.

Funding Insights of AIVF

AIVF has successfully raised a total of $25M through 1 strategic funding round. The most recent funding activity was a Series A round of $25 million completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $25M
  • Total Rounds 1
  • Last Round Series A β€” $25M
  • First Round $25M

    (Jun 2022)

  • Investors Count 2

All 1 funding rounds of AIVF with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2022$25MSeries A–Insight Partners
Valuation history

2 investors in total: 1 institutional and 1 angel.

Investors in AIVF

AIVF has secured backing from 2 investors, including venture fund and angel investors. Prominent investors backing the company include Insight Partners and Dan Ariely.

All
Venture Fund
Angel
InvestorDescriptionFounded YearDomainLocation
Investment firm scaling software and technology companies from early to late stages.
insightpartners.com

Dan Ariely

Behavioral economist, author, and angel investor in tech and consumer startups.
unknown_2b64a733dae64138b
Premium access

Investor details for AIVF

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of AIVF

20 people are tracked at AIVF (10 in leadership, 5 in board & advisors, 5 in team).

NameRoleGroup
Daniel Seidman
Co-Founder & CMOLeadership
Daniella Gilboa
Co-Founder & CEOLeadership
Eyal Schiff
Co-Founder & Board MemberLeadership
Yariv Zur
VP ProductLeadership
Jason Krebs
Chief Business OfficerLeadership
Dan Ariely
Chief Behavioral OfficerLeadership
Amir Sarig
CFOLeadership
Assaf Shisha-Halevy
Director Of Customer SuccessLeadership
Benzi Ronen
Founder CoachLeadership
Tal Weiner
Director Of Regulatory AffairsLeadership
Colin Howles
Board MemberBoard & advisors
Lee Shulman
Board MemberBoard & advisors
Nikica Zaninovic
Board MemberBoard & advisors
Barry Behr
Board MemberBoard & advisors
Marcos Meseguer
Board MemberBoard & advisors
Eyal Ohayon
Evp, EngineeringTeam
Noa Shachen Tov
HR ManagerTeam
Ella Mozes
Technical Support EngineerTeam
Orion Sasoni
Senior Backend EngineerTeam
Roy Arad
InvestorTeam
Premium access

Complete people profiles for AIVF

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by AIVF

AIVF has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include ART Compass.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
EHR and practice management app for IVF clinics is provided.
artcompass.ioSan Diego, United States2018Oct 2022β€’β€’β€’β€’
Premium access

Complete acquisition details for AIVF

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of AIVF

3 dated milestones of AIVF across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded AIVF is founded.
  2. Funding First funding round of $25.0M.
  3. Acquisition Acquires ART Compass.

Web traffic of AIVF

The website of AIVF (aivf.co) receives about 17.2K visits a month.

  • Monthly visits
    17.2K

    ▲ 13.3% vs previous month

Similar websites

Websites whose visitors overlap most with AIVF. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
dandifertility.com
100%
11.8K#1,745,091View details
indoreinfertilityclinic.com
indoreinfertilityclinic.com
82%
#2,454,568–
prideivf.com
prideivf.com
80%
#3,401,114–
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Aivf

Premium access

Complete news archive for AIVF

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about AIVF

AIVF was founded in 2018 and raised its 1st funding round 4 years after it was founded.

AIVF is headquartered in Tel Aviv, Israel.

Daniella Gilboa is the CEO of AIVF, as recorded in our data. They have also founded this company.

AIVF is a funded company, having raised a total of $25M across 1 funding round to date. The company's 1st funding round was a Series A of $25M, raised on Jun 2022.

AIVF was established in 2018 in Tel Aviv, Israel, within the healthcare technology sector. An AI-driven diagnosis platform for in vitro fertilization (IVF) is offered. Images and videos of developing embryos are examined through deep learning algorithms. Patient electronic medical records, genomic information, and visual data are integrated to inform critical decisions in treatment processes. Operations focus on supporting fertility clinics with data-driven insights.

AIVF offers EMA Platform, AIVF Day-3, AIVF Day-5, and AIVF Genetics.

AIVF has made 1 acquisition, including ART Compass.

AIVF has 2 investors. Key investors include Insight Partners, and Dan Ariely.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available